Aficamten reduces cardiac contractility by modifying the actomyosin interaction.

Moussavi-Harami, Farid; Regnier, Michael

Moussavi-Harami, Farid; Regnier, Michael.

Affiliation

Moussavi-Harami F; Division of Cardiology, Department of Medicine, University of Washington City, Seattle, WA, USA.
Regnier M; Department of Laboratory Medicine and Pathology, University of Washington, City, Seattle, WA, USA.

Nat Cardiovasc Res ; 3(8): 893-894, 2024 Aug.

Article in En | MEDLINE | ID: mdl-39196033

Subject(s)

Actomyosin; Myocardial Contraction; Animals; Humans; Actomyosin/metabolism; Myocardial Contraction/drug effects; Myocardial Contraction/physiology; Myocytes, Cardiac/metabolism; Myocytes, Cardiac/drug effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Actomyosin / Myocardial Contraction Limits: Animals / Humans Language: En Journal: Nat Cardiovasc Res Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google